Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Digital Health Trends 2024 - Implications for Research and Patient Care

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE

Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Nephrology

Boost Development with Expertise and 
Connections

With 850 million people living with kidney disease, the need for new treatments has never been higher. Developing therapies is challenging; finding the right patients at the right time is just the beginning. Our team of experts offer the support needed to navigate these challenges and work with you on bringing global nephrology solutions to market faster. Our experienced renal team is ready to help.

CONTACT US
Solutions Therapeutics Nephrology

Connecting patients, sites and sponsors

Many kidney patients suffer significant quality of life challenges and comorbidities. This makes recruitment and retention challenging, particularly in rare kidney diseases.

Whether a glomerular or genetic disease, dialysis or nondialysis kidney disease, or a cell and gene therapy treatment, IQVIA’s site relationships and strategic alliances with dialysis centers, academic sites, nephrologists and endocrinologists help ensure we meet your patient recruitment and retention goals. In fact, IQVIA’s data-driven site selection over the last three years resulted in a two times higher recruitment rate in Phase III nephrology studies.

2x higher recruitment

when using IQVIA's site selection for Phase III nephrology studies

50% fewer deviations

when using IQVIA's protocol assessment for Phase III nephrology studies

Power your nephrology trials

Renal trials can be challenged by finding the right sites and investigators, slow start up, and low recruitment and retention rates. Our experienced team is here to help.

IQVIA intelligently connects and leverages real world data, historical site performance, patient-centered technology and analytics to power your trial from the start.

Real time lab alerts, centralized monitoring of lab samples and eCOA allow for better data quality with less missing data and the ability to efficiently complete your primary analysis, accelerating your road to approval.

Unleash new opportunities with IQVIA Connected Intelligence™

Our connected approach to clinical development brings together expansive nephrology experience and capabilities, real world data, advanced analytics and innovative technologies. The results?

  • Drive study speed and efficiency using protocol assessments, AI-powered site identification and predictive recruitment
  • Create new connections between sponsors, patients and sites to enable better decision making and retain patients
  • Innovate with less risk through novel trial design including basket, adaptive, and decentralized models

Related solutions

Diabetes

Understand the science in treating diabetes with broadening populations, expanding treatment options, and new digital support tools.

Rare Diseases

Build on our experience of more than 245 rare disease studies in 96 countries to fulfill your promise of hope to millions around the world.

Cell & Gene Therapy

Access new resources for advanced therapy development, from candidate identification through market authorization.

Contact Us